BrainsWay Statistics
Total Valuation
BrainsWay has a market cap or net worth of $506.80 million. The enterprise value is $453.72 million.
| Market Cap | 506.80M |
| Enterprise Value | 453.72M |
Important Dates
The next estimated earnings date is Tuesday, November 10, 2026, before market open.
| Earnings Date | Nov 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BrainsWay has 40.13 million shares outstanding. The number of shares has increased by 2.01% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 40.13M |
| Shares Change (YoY) | +2.01% |
| Shares Change (QoQ) | +1.43% |
| Owned by Insiders (%) | 13.50% |
| Owned by Institutions (%) | 26.56% |
| Float | 24.14M |
Valuation Ratios
The trailing PE ratio is 53.68 and the forward PE ratio is 34.85.
| PE Ratio | 53.68 |
| Forward PE | 34.85 |
| PS Ratio | 8.35 |
| Forward PS | 6.59 |
| PB Ratio | 6.40 |
| P/TBV Ratio | 6.40 |
| P/FCF Ratio | 87.59 |
| P/OCF Ratio | 66.95 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 53.49, with an EV/FCF ratio of 78.42.
| EV / Earnings | 48.06 |
| EV / Sales | 7.48 |
| EV / EBITDA | 53.49 |
| EV / EBIT | 59.98 |
| EV / FCF | 78.42 |
Financial Position
The company has a current ratio of 3.59, with a Debt / Equity ratio of 0.09.
| Current Ratio | 3.59 |
| Quick Ratio | 3.05 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.77 |
| Debt / FCF | 1.23 |
| Interest Coverage | 4.87 |
Financial Efficiency
Return on equity (ROE) is 12.82% and return on invested capital (ROIC) is 30.70%.
| Return on Equity (ROE) | 12.82% |
| Return on Assets (ROA) | 4.05% |
| Return on Invested Capital (ROIC) | 30.70% |
| Return on Capital Employed (ROCE) | 7.62% |
| Weighted Average Cost of Capital (WACC) | 4.91% |
| Revenue Per Employee | $470,504 |
| Profits Per Employee | $73,186 |
| Employee Count | 129 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 2.60 |
Taxes
In the past 12 months, BrainsWay has paid $236,000 in taxes.
| Income Tax | 236,000 |
| Effective Tax Rate | 2.44% |
Stock Price Statistics
The stock price has increased by +64.58% in the last 52 weeks. The beta is 0.08, so BrainsWay's price volatility has been lower than the market average.
| Beta (5Y) | 0.08 |
| 52-Week Price Change | +64.58% |
| 50-Day Moving Average | 14.48 |
| 200-Day Moving Average | 13.76 |
| Relative Strength Index (RSI) | 29.34 |
| Average Volume (20 Days) | 93,877 |
Short Selling Information
The latest short interest is 199,566, so 0.65% of the outstanding shares have been sold short.
| Short Interest | 199,566 |
| Short Previous Month | 208,111 |
| Short % of Shares Out | 0.65% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.28 |
Income Statement
In the last 12 months, BrainsWay had revenue of $60.70 million and earned $9.44 million in profits. Earnings per share was $0.23.
| Revenue | 60.70M |
| Gross Profit | 45.72M |
| Operating Income | 7.57M |
| Pretax Income | 9.68M |
| Net Income | 9.44M |
| EBITDA | 8.48M |
| EBIT | 7.57M |
| Earnings Per Share (EPS) | $0.23 |
Balance Sheet
The company has $62.11 million in cash and $7.13 million in debt, with a net cash position of $54.98 million or $1.37 per share.
| Cash & Cash Equivalents | 62.11M |
| Total Debt | 7.13M |
| Net Cash | 54.98M |
| Net Cash Per Share | $1.37 |
| Equity (Book Value) | 79.19M |
| Book Value Per Share | 1.97 |
| Working Capital | 58.75M |
Cash Flow
In the last 12 months, operating cash flow was $7.57 million and capital expenditures -$1.78 million, giving a free cash flow of $5.79 million.
| Operating Cash Flow | 7.57M |
| Capital Expenditures | -1.78M |
| Depreciation & Amortization | 918,000 |
| Net Borrowing | -780,000 |
| Free Cash Flow | 5.79M |
| FCF Per Share | $0.14 |
Margins
Gross margin is 75.32%, with operating and profit margins of 12.46% and 15.55%.
| Gross Margin | 75.32% |
| Operating Margin | 12.46% |
| Pretax Margin | 15.94% |
| Profit Margin | 15.55% |
| EBITDA Margin | 13.98% |
| EBIT Margin | 12.46% |
| FCF Margin | 9.53% |
Dividends & Yields
BrainsWay does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.01% |
| Shareholder Yield | -2.01% |
| Earnings Yield | 1.86% |
| FCF Yield | 1.14% |
Analyst Forecast
The average price target for BrainsWay is $19.27, which is 54.16% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $19.27 |
| Price Target Difference | 54.16% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 24.64% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 4, 2026. It was a forward split with a ratio of 2:1.
| Last Split Date | Mar 4, 2026 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
BrainsWay has an Altman Z-Score of 6.15 and a Piotroski F-Score of 5.
| Altman Z-Score | 6.15 |
| Piotroski F-Score | 5 |